Nigeria’s pharmaceutical retail sector has continued to grow at a remarkable pace, driven by rising health consciousness, expanding urban centres, and increasing demand for convenient and reliable healthcare services.
By 2025, several pharmacy chains have strengthened their positions as industry leaders, leveraging both extensive physical outlets and advanced digital platforms to serve millions of Nigerians across the country.
The expansion of these pharmacy chains reflects broader growth in Nigeria’s healthcare industry. Increasing consumer expectations, digital transformation, improved supply chains, and regulatory reforms continue to push the sector forward.
As competition intensifies, pharmacy chains are investing heavily in e-commerce, home delivery, telehealth, and integrated care services to meet evolving customer needs.
By 2025, Nigeria’s pharmacy retail market is not only larger but also more innovative, competitive, and customer-focused—setting the stage for even greater transformation in the years ahead.
To determine the largest and most influential pharmacy chains, Nairametrics consulted industry experts, engaged frequent pharmacy users, and analysed online customer reviews to assess their reach, visibility, and overall impact.
Below is a list of the major pharmacy chains shaping Nigeria’s healthcare retail landscape in 2025.
Neimeth International Pharmaceuticals Plc emerged after a management buyout led by Mazi Sam I. Ohuabunwa, following Pfizer Inc.’s decision to divest its 60% equity stake in Pfizer Products Plc. The buyout, completed in May 1997, came as part of Pfizer’s global repositioning strategy, allowing the existing management team in Nigeria to take full operational control and rebrand the company as Neimeth.
Although widely recognised as one of Nigeria’s oldest and most established pharmaceutical manufacturers, Neimeth also operates a network of pharmacy outlets and distribution centres across the country. Its vertically integrated model, which combines drug manufacturing, wholesale distribution, and pharmacy services, gives the company a distinctive position within the healthcare value chain.
Consumers who spoke with Nairametrics praised Neimeth for its commitment to quality, innovation, and local research—particularly noting products like Ciklavit, a well-known medication for managing sickle cell symptoms. These locally sourced and locally produced solutions have earned the company admiration in public health circles.
However, some customers expressed concerns about the affordability of certain Neimeth products, noting that while quality is high, pricing can be a barrier for lower-income patients.
Despite these concerns, Neimeth remains a key player in Nigeria’s pharmaceutical landscape, balancing its legacy as a manufacturer with a growing presence in retail and distribution.
